RCM
MED icon

Riverhead Capital Management’s Medifast MED Stock Holding History

Riverhead Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$218K Hold
2,100
– – 0.01% 1098
2019
Q2 		$269K Hold
2,100
– – 0.01% 1017
2019
Q1 		$268K Hold
2,100
– – 0.01% 992
2018
Q4 		$263K Hold
2,100
– – 0.01% 948
2018
Q3 		$465K Buy
2,100
+700
+50% +$142K 0.02% 778
2018
Q2 		$224K Buy
+1,400
New +$179K 0.01% 1037

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverhead Capital Management's MED Position: Q3 2019 in Review

Riverhead Capital Management held its Medifast (MED) position steady in Q3 2019 at 2,100 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #1098.

Riverhead Capital Management first reported a position in MED in Q2 2018 and has held it in 6 quarters since. The position peaked at $465K in Q3 2018. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Riverhead Capital Management held 2,100 shares of Medifast worth $218K as of Q3 2019.
  • Riverhead Capital Management left its Medifast share count unchanged in Q3 2019.
  • Medifast made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1098 holding.
  • Riverhead Capital Management first reported a position in Medifast in Q2 2018 and has held it in 6 quarters since.
  • Riverhead Capital Management's Medifast position peaked at $465K in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.